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Protein oligomerizationLysenin is a self-assembling, pore-forming toxin which speciﬁcally recognizes sphingomyelin. Mutation of
tryptophan 20 abolishes lysenin oligomerization and cytolytic activity. We studied the interaction of lyseninWT
and W20A with sphingomyelin in membranes of various lipid compositions which, according to atomic force
microscopy studies, generated either homo- or heterogeneous sphingomyelin distribution. Liposomes composed
of SM/DOPC, SM/DOPC/cholesterol and SM/DPPC/cholesterol could bind the highest amounts of GST-lysenin
WT, as shown by surface plasmon resonance analysis. These lipid compositions enhanced the release of
carboxyﬂuorescein from liposomes induced by lysenin WT, pointing to the importance of heterogeneous
sphingomyelin distribution for lysenin WT binding and oligomerization. Lysenin W20A bound more weakly to
sphingomyelin-containing liposomes than did lysenin WT. The same amounts of lysenin W20A bound to
sphingomyelin mixed with either DOPC or DPPC, indicating that the binding was not affected by sphingomyelin
distribution in the membranes. The mutant lysenin had a limited ability to penetrate hydrophobic region of the
membrane as indicated bymeasurements of surface pressure changes.Whenapplied to detect sphingomyelin on
the cell surface, lysenin W20A formed large conglomerates on the membrane, different from small and regular
clusters of lysenin WT. Only lysenin WT recognized sphingomyelin pool affected by formation of raft-based
signaling platforms. During fractionation of Triton X-100 cell lysates, SDS-resistant oligomers of lysenin WT
associatedwithmembrane fragments insoluble in Triton X-100whilemonomers of lyseninW20A partitioned to
Triton X-100-soluble membrane fractions. Altogether, the data suggest that oligomerization of lysenin WT is a
prerequisite for its docking in raft-related domains.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Sphingomyelin is a major lipid of the plasma membrane located
mainly in its outer leaﬂet. Due to the high content of saturated acyl
chains, sphingomyelin together with glycolipids and cholesterol
formsmicrodomains, named rafts [1,2]. The content of sphingomyelin
in rafts exceeds by 20–30% that in the bulk of the plasmamembrane as
found by mass spectrometry analysis [3,4]. The unique lipid
environment of rafts facilitates local accumulation of distinct proteins,
including those anchored in the outer leaﬂet by a glycosylpho-
sphatidylinositol moiety, and Src family kinases docked in the inner
leaﬂet of rafts via saturated fatty acid residues [5–7]. The dense
packing of lipid molecules within raft renders them resistant to
solubilization in non-ionic detergents, a property used widely for
biochemical studies of raft composition and function [8,9]. Ample data+48 22 822 5342.
ll rights reserved.indicate that rafts serve as signaling platforms for various receptors,
among which immunoreceptors and death receptors are the most
thoroughly studied in terms of their association with rafts for signal
generation [10–12]. It has been found that activation of TNF receptor
family members and immunoreceptor FcγRIIA triggers so-called
sphingomyelin cycle which starts from sphingomyelin hydrolysis
yielding ceramide. The ceramide favors clustering of the receptors in
the plane of the plasma membrane and their association with rafts,
but the lipid also serves as an intracellular second messenger [12–16].
The structural and signaling roles of sphingomyelin imply the
existence of various pools of the lipid in the plasma membrane, as
indicated also by scarce experimental data [17,18]. Studies on raft and
non-raft sphingomyelin and its dynamics are likely to be facilitated by
application of sphingomyelin-speciﬁc probes, such as equinatoxin II,
lysenin and lysenin-related proteins [19–21]. Lysenin is a 297 amino
acid-long toxin originating from the coelomic ﬂuid of the earthworm
Eisenia foetida which speciﬁcally recognizes sphingomyelin among
lipids [22–24]. These data are in line with other biophysical studies on
the interaction of lysenin with sphingomyelin showing that the
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membrane [25]. Yet, the application of lysenin for studies of
sphingomyelin organization in the plasma membrane is hindered by
the lytic activity of the protein. Upon sphingomyelin binding, lysenin
forms stable hexamers detectable by SDS-gel electrophoresis and
electron microscopy. Oligomerization of lysenin is facilitated by
cholesterol which increases ﬂuidity of sphingomyelin-containing
membranes and promotes separation of sphingomyelin-rich liquid-
ordered phase [26–28]. Lysenin hexamers, formed in the sphingo-
myelin-containing membranes, are responsible for the channel
activity of the toxin and its lytic property [28]. The recognition of
sphingomyelin by lysenin and effective membrane-binding is of
complex nature and requires participation of ﬁve of the six
tryptophan residues scattered throughout the polypeptide [23,29].
Mutation of tryptophan 20 resulted in a loss of oligomerization and of
the cytolytic activity of lysenin with maintenance of sphingomyelin
binding [28]. Due to the lack of the lytic activity, the mutant lysenin
W20A is of interest as a potential probe for studying sphingomyelin
organization in the plasma membrane of living cells.
Recently, a truncated form of lysenin devoid of 160 N-terminal
amino acids, named non-toxic protein, was used to analyze
distribution of sphingomyelin in the plasma membrane of Jurkat
cells. The sphingomyelin pool recognized by this truncated lysenin
was spatially and functionally separated from GM1- and T cell
receptor-enriched rafts [30]. It is not known, however, whether
monomers of the non-toxic lysenin have the same sphingomyelin
binding properties as the wild-type lysenin. Here we used GST-
lysenin WT and GST-lysenin W20A to examine if both forms of the
protein recognize assemblies of sphingomyelin in membranes.
Determining whether homo- or heterogeneous distribution of
sphingomyelin in the membrane favors/disfavors sphingomyelin
recognition by WT and W20A lysenin should indicate whether the
two proteins target the same pool of sphingomyelin in the plasma
membrane. Our data indicate that W20A mutation has deprived
lysenin of its ability to bind preferentially sphingomyelin clusters in
membranes. Accordingly, fractionation of Triton X-100 lysates of cells
revealed that GST-lysenin WT, but not GST-lysenin W20A, bound
exclusively to sphingomyelin located in plasma membrane fragments
resistant to the detergent, which pointed to their raft origin.
2. Materials and methods
2.1. Plasmids and protein puriﬁcation
The plasmids expressing lysenin WT and lysenin W20A with a
glutathione-S-transferase (GST) tag at the N-terminus were generat-
ed from pT7RS-lysenin WT and pT7RS-lysenin W20A templates,
whichwere constructed as described before [28]. The cDNA fragments
encoding the two proteins were ampliﬁed by PCR and subcloned to
the pGEX-4T-3 vector (Amersham) using EcoRI/BamHI restriction
sites. For preparation of GST protein, empty pGEX-4T-3 vector was
used. Escherichia coli was transformed with corresponding plasmids
and the recombinant proteins were puriﬁed on a glutathione-agarose
column according to manufacturer's instructions (Sigma).
2.2. Surface plasmon resonance (SPR)
The analysis was conducted at 25 °C on a BIAcore X apparatus
(BIAcore, GE Healthcare) equipped with an L1 chip coated with large
unilamellar vesicles (LUV) of various lipid compositions. Bovine brain
semi-synthetic sphingomyelin (SM), cholesterol, dioleoyl phosphati-
dylcholine (DOPC), dipalmitoyl phosphatidylcholine (DPPC) were
from Avanti Polar Lipids and Sigma. Appropriate mixtures of lipids:
SM/DOPC or SM/DPPC at molar ratio 1:1 with or without cholesterol
equimolar to SM, DOPC/cholesterol or DPPC/cholesterol atmolar ratio
1:1, and DOPC or DPPC alone, were dried from chloroform:methanol(1:1, v:v) on a rotavapor for 3 h. The lipid ﬁlm was resuspended in
buffer A (150 mM NaCl, 30 mM Tris, pH 8.0), vortexed and freeze–
thawed six times. The resulting multilamellar vesicles were extruded
through polycarbonate ﬁlters with 100 nm pores to create LUV. The
concentration of lipidswith a choline head groupwas determinedwith
Phospholipids B Kit (Wako Chemicals, Germany) and kept at 2 mM.
The chip was ﬁrst equilibrated with ﬁltered and degassed running
buffer A. Prior to coating with LUV, the surface of the chip was cleaned
with three consecutive injections of isopropanol/50mMNaOH (2:3, v:
v) for 1 min at 30 μl/min. Liposomes were deposited on the chip at a
low ﬂow rate of 1 μl/min for 10 min. The amount of deposited
liposomes corresponded to 700–900 resonance units (RU). Binding
experiments were performed with 2 μM solution of GST-lysenin WT,
GST-lysenin W20A or GST in buffer A applied at a ﬂow rate of 30 μl/
min. After 300 s (association phase) deposited material was washed
with buffer A for another 300 s (dissociation phase).
2.3. Surface pressure measurements
The experiments were carried out with a NIMA Technology
tensiometer model PS3 (Coventry, UK) at 23±1 °C in darkness
under argon atmosphere, essentially as described earlier [31]. The
lipid composition of monolayers was: SM/DOPC/cholesterol at molar
ratio 3:7:3 or DOPC/cholesterol at molar ratio 7:3. The total
phospholipid concentration was 1 mM. The measurements of surface
pressure as a function of time allows the membrane insertion kinetics
to be determined by applying the following exponential equation:
π − π0ð Þ= π∞ − π0ð Þ = A 1−e−αt
 
+ 1− Að Þ 1− e−βt
 
ð1Þ
where π, πo, π∞ are values of the surface pressure at time t (π), at the
moment of injection of the protein (1–30 nM) to the aqueous sub-
phase (πo), and the plateau (π∞), A is a pre-exponential factor, and α
and β are the rate constants of the fast and slow phase of protein
adsorption at the interface. The average rate constant Q represents
relative efﬁciency of insertion calculated as
Q = A  α + 1− Að Þ  β: ð2Þ
2.4. Atomic force microscopy measurements
Imaging was performed at 23 °C using a Nanosurf easyScan 2 AFM
system. First, a monolayer composed of pure stearic acid prepared by
repeated crystallization was deposited onto the mica surface by the
Langmuir–Blodgett technique with a speed of lift of 1 mm/min.
Monolayers composed of SM/DOPC/cholesterol or SM/DPPC/choles-
terol (molar ratio 3:7:3), SM/DOPC or SM/DPPC (molar ratio 3:7)
with 1 mM total phospholipid concentration were pre-formed on the
surface of a buffer (150 mM NaCl, 50 mM Tris, pH 8.0) in a Teﬂon
trough at the surface pressure of 21 mN/m and maintained constant
by computer control. Monolayers were next deposited on the mica-
stearic acid support and dried. This experimental design created mica
surface exposing the hydrophobic fatty acyl chains of stearic acid for
interaction with fatty acyl chains of lipids from the examined
monolayers. Consequently, the monolayers oriented themselves
with the lipid polar headgroups toward the environment. Images
were taken in the dynamic mode with a silicon cantilever with a
spring constant of 48 N/m and a tip with a radius of curvature less
than 10 nm. The scanning rate was 1 Hz and 256×256 data points
were acquired. Image data were ﬂattened after acquisition.
2.5. Carboxyﬂuorescein release from LUV
LUV composed of SM/DOPC or SM/DPPC (molar ratio 3:7) with or
without cholesterol equimolar to SM were prepared as described
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A at pH 7.6, containing 50 mM 6-carboxyﬂuorescein (Sigma). LUV
were separated from external dye by pelleting (10 min, 10,000g,
25 °C) and suspended in buffer A (pH 7.6). The total concentration of
phospholipids in the suspension was 1 mM; 0.5 ml of the LUV
suspension was placed in a cuvette. Measurements were done on a
Spex spectroﬂuorimeter (Jobin-Yvone) at Em/Ex=490/520 nm
(25 °C). Before adding proteins, ﬂuorescence was monitored for
10 min to establish level of spontaneous efﬂux of the dye (Fi).
Subsequently, at time set as 0, GST-lysenin WT or GST-lysenin W20A
was added to LUV suspension (100 nM ﬁnal protein concentration)
and the ﬂuorescence (F) was measured during 10 min (25 °C). The
maximal efﬂux of 6-carboxyﬂuorescein (Ff) was determined in the
presence of 0.1% Triton X-100. The results were expressed as % dye
leakage=100(F−Fi)/(Ff−Fi), according to ref [32].2.6. Localization of lysenin, FcγRIIA and tyrosine-phosphorylated
proteins at the plasma membrane
Transfected BHK cells stably expressing FcγRIIA were incubated
with mouse anti-FcγRIIA IgG2b (clone IV.3, ATCC) for 20 min at 4 °C
and either ﬁxed with 3% paraformaldehyde to maintain non-
activated receptor or incubated with goat anti-mouse IgG-Texas
Red (Jackson ImmunoResearch) (15 min, 4 °C) to cross-link and
activate the receptor [10]. After ﬁxation cells were treated with
50 mM NH4Cl, blocked with 3% ﬁsh gelatine and incubated with
20 nM GST-lysenin WT or 200 nM GST-lysenin W20A (30 min,
25 °C). After washing, the cells were exposed to rabbit anti-lysenin
IgG (30 min, 25 °C) followed by goat anti-rabbit IgG-FITC (Rockland).
Non-activated cells were additionally incubated with goat anti-
mouse IgG-Texas Red to visualize FcγRIIA. To visualize tyrosine-
phosphorylated proteins, ﬁxed cells were permeabilized either with
0.05% Triton X-100 (5 min, 4 °C) or 0.005% digitonin (10 min, 25 °C),
incubated with 3% ﬁsh gelatine (twice for 30 min, 25 °C) and treated
with rabbit anti-phosphotyrosine IgG (Transduction Laboratories)
and goat anti-rabbit IgG-FITC (1 h each incubation, 25 °C). In a series
of experiments, cells were exposed to Triton X-100 or digitonin prior
to labeling of lysenin on the cell surface as above. The samples were
mounted in Mowiol/DABCO (1,4-diazabicyclo[2,2,2]-octane) and
examined under a Nikon ﬂuorescence microscope equipped with a
DXM 120 °C digital camera and analyzed for protein clustering using
ImageJ software (NIH) as described [33]. For each variant of
experiment 10–12 cell images were analyzed from two independent
experiments.
For colocalization analysis, confocal imaging was performed on a
Leica microscope (TCS SP5) equipped with a 100X, N.A. 1.4
objective. FITC and Texas Red conjugated with appropriate anti-
bodies were excited with 488 nm Ar and 594 nm HeNe lasers,
respectively, in the mode of sequential excitation to exclude cross-
over of their ﬂuorescence. Stacks of 5–7 confocal planes (at 0.2 μm
step) with a 4.5 zoom factor were acquired for each analyzed cell
with attention paid to regions encompassing ﬂat lamellae. The
settings of photomultipliers were adjusted to obtain comparable
ranges of pixel intensity in each channel (mean intensity values
about 20 on a scale from 0 to 255), the speed of scanning was
200 Hz, scan resolution 1024x1024 pixels. Colocalization analysis
was performed according to [34] using Leica Application Suite AF
software which calculated Pearson's correlation coefﬁcient, overlap
coefﬁcient and colocalization rate (colocalization area divided by
foreground area) for each pair of images. For both signals the
intensity threshold value was set at 40%, and 20% background
subtraction was applied. The analysis was performed in two single-
plane confocal images acquired from the lamella of one cell; at least
40 cells from three independent experiments were analyzed for
each variant.2.7. Cell fractionation
U937 cells were treated with 20 nM GST-lysenin WT or 200 nM
GST-lysenin W20A for 20 min at 4 °C. To activate FcγRIIA, cells were
exposed to anti-FcγRIIA (mouse IgG2b, clone IV.3) conjugated with
biotin and followed by goat anti-mouse IgG (Sigma). In cells treated
with IV.3-biotin alone, FcγRIIA remained non-activated [10,16]. For
fractionation, cells (5×106) were lysed in the presence of 0.2% Triton
X-100 and subjected to ultracentrifugation in 0–40% OptiPrep density
gradient [35]. Gradient fractions were analyzed by SDS-PAGE (4–15%)
and immunoblotting using rabbit IgG against the GST tag (Sigma),
Lyn kinase (Santa Cruz Biotechnology) and NTAL (kindly provided by
Dr. V. Horejsi, Prague), all followed by goat anti-rabbit IgG-peroxidase
(ICN). To detect the biotin-labeled anti-FcγRIIA antibody, goat anti-
biotin IgG-peroxidase (Sigma) was applied. Immunoreactive bands
were detected with SuperSignal West Pico chemiluminescent
substrate (Pierce).
3. Results
3.1. Surface plasmon resonance analysis of GST-lysenin WT and
GST-lysenin W20A interaction with sphingomyelin
To investigate the mode of lysenin interaction with sphingomyelin
in membranes, we performed surface plasmon resonance analysis on
liposomes composed of sphingomyelin mixed either with DOPC or
DPPC (molar ratio 1:1). Such lipid composition was expected to
induce heterogeneous or homogenous sphingomyelin distribution in
the plane of the membrane, respectively [36–39]. GST-lysenin WT
bound strongly to the SM/DOPC liposomes as indicated by the
resonance value of about 5300 RU after 5 min of dissociation (600 s
from the beginning of the measurements) (Fig. 1A). The dissociation
phase which started at 300 s with washing of samples with a buffer
showed the amount of the protein stably associated with the
liposomes and was taken into consideration when comparing the
binding of lysenin to liposomes of various composition. The binding of
GST-lysenin WT to SM/DOPC liposomes was approximately twice as
strong as the binding to the SM/DPPC ones. GST-lysenin WT failed to
bind to DOPC or DPPC alone, pointing to the speciﬁcity of the protein
toward sphingomyelin (Fig. 1A). As lysenin interaction with sphingo-
myelin is likely to involve the conserved tryptophan residues of the
protein [23], we examined the membrane interaction of GST-lysenin
W20A. The mutant lysenin bound more weakly to sphingomyelin-
containing liposomes than did WT lysenin, however, it still preferred
sphingomyelin-containingmembranes over those containing DOPC or
DPPC alone (Fig. 1B). In contrast to lyseninWT, themutant protein did
not display a signiﬁcant difference in the binding to sphingomyelin
mixed with DOPC or DPPC (Fig. 1B).
The inﬂuence of sphingomyelin clustering on the binding of
lysenin was further examined after supplementation of SM/DPPC
liposomes with cholesterol (molar ratio 1:1:1), as cholesterol was
likely to facilitate the formation of sphingomyelin-rich domains in
this lipid mixture [25,40]. Under these conditions the amount of
GST-lysenin WT bound to the membrane was signiﬁcantly increased
(approximately ∼6000 versus ∼2000 RU after 5 min of dissociation,
in the presence and absence of cholesterol, respectively). As a result,
the binding of GST-lysenin WT to SM/DPPC/cholesterol liposomes
approached the maximum level found for the SM/DOPC/cholesterol
and SM/DOPC liposomes (Fig. 1A). Incorporation of cholesterol to
sphingomyelin-containing liposomes also improved the binding of
GST-lysenin W20A. The effect of cholesterol on the mutant lysenin
binding was similar for SM/DOPC and SM/DPPC membranes
(Fig. 1B). In contrast, addition of cholesterol to liposomes containing
DOPC or DPPC (at a molar ratio of 1:1 to PC) made the binding of
GST-lysenin WT and W20A the weakest among all liposomes
tested (Fig. 1A and B). GST alone did not bind to any liposomes
Fig. 1. Lysenin binding to liposomes of various lipid compositions. The following lipid mixtures were used: SM/DOPC or SM/DPPC (molar ratio 1:1) with or without cholesterol in
equimolar amounts to SM, DOPC/cholesterol or DPPC/cholesterol (molar ratio 1:1) and DOPC or DPPC alone. SPR sensograms of GST-lysenin WT (A) and the mutant GST-lysenin
W20A (B) binding to liposomes immobilized on the surface of sensor chip L1. Proteins (2 μM) were injected at a ﬂow rate of 30 μl/min in 150 mM NaCl, 30 mM Tris, pH 8.0. In (A) a
sensogram of GST (2 μM) binding to SM/DOPC/cholesterol liposomes is also seen. Typical sensograms from three or four independent experiments are presented.
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affect the interaction of GST-lysenin WT and W20A with the
membranes.
3.2. Atomic force microscopy studies of sphingomyelin-containing
monolayers
For analysis of the topography of monolayers of various lipid
compositions, the monolayers were transferred to the mica-stearic
acid support and examined by atomic force microscopy. The studies
revealed phase separation in SM/DOPC but not in SM/DPPC
membranes (molar ratio 3:7; Fig. 2A and C). The SM/DPPC membrane
was ﬂat and essentially featureless (Fig. 2C), which is in agreement
with earlier data on miscibility of C16:0 sphingomyelin and DPPC
obtained by differential scanning calorimetry [36]. In contrast, in
images of SM/DOPC membranes interspersed small and large
domains (0.1–1 μm in diameter) raised above the surrounding
monolayer were seen (Fig. 2A, lighter areas). These distinct areas
can correspond to sphingomyelin-rich domains as suggested earlier
[37,38]. Membranes of SM/DOPC/cholesterol (molar ratio 3:7:3) had
an appearance resembling that of membranes without cholesterol
(Fig. 2B). In contrast, SM/DPPC membranes supplemented with
cholesterol underwent reorganization, displayed numerous dispersed
raised islands 0.1–0.4 μm in diameter (Fig. 2D), indicating that at these
conditions phase separation occurred.3.3. GST-lysenin W20A binds sphingomyelin but lacks lytic activity
As the binding of GST-lysenin WT to sphingomyelin-containing
membranes coincides with protein oligomerization and membrane
permeation [26,28], we performed experiments with release of
carboxyﬂuorescein from liposomes of various lipid composition. We
found that GST-lyseninWT released carboxyﬂuorescein 1.9-fold more
effectively from SM/DOPC liposomes than from SM/DPPC ones, as
estimated after 10 min of the dye efﬂux (molar ratio of SM to DOPC or
DPPC was 3:7). Supplementation of the liposomes with cholesterol in
ratio equimolar to SM led to an increase in the level of permeabiliza-
tion by about 1.4-fold from SM/DOPC and about 2.4-fold from SM/
DPPC liposomes (Fig. 3). The data on the permeabilizing activity of
GST-lysenin WT were in agreement with the SPR studies on the
binding of the proteins to various liposomes (Fig. 1A). GST-lysenin
W20A did not induce release of carboxyﬂuorescein from liposomes
regardless of their lipid composition (Fig. 3). The loss of permeabiliz-
ing activity of GST-lysenin W20A correlated with its inability to form
SDS-resistant oligomers (Fig. 3). It has to be emphasized that the
mutant lysenin did bind tomembranes in a sphingomyelin-dependent
manner, albeit less strongly than did lysenin WT (see Fig. 1B). The
protein–lipid overlay assaywhich relied on binding of lysenin to lipids
deposited onto nitrocellulose [28] conﬁrmed that the binding of
GST-lysenin W20A to sphingomyelin was about 8-fold weaker than
that of GST-lysenin WT (not shown).
Fig. 2. AFM images of membranes of different composition. (A) SM/DOPC (molar ratio 3:7), (B) SM/DOPC/cholesterol (molar ratio 3:7:3), (C) SM/DPPC (molar ratio 3:7) and (D)
SM/DPPC/cholesterol (molar ratio 3:7:3) membranes. For imaging, monolayers were deposited on mica-stearic acid support at surface pressure of 21 mN/m.
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To further study the interactions of GST-lysenin WT and W20A
with model membranes, monomolecular surface pressure experi-
ments were undertaken, starting with an analysis of spontaneous
adsorption of the protein at the argon–water interface. Injection of
GST-lysenin WT into the aqueous sub-phase led to an increase of
surface pressure in a dose-dependent manner (Fig. 4A), as a result of
the surface-active properties of lysenin molecules. At low proteinFig. 3. Lytic activity of lysenin correlates with its oligomerization. Carboxyﬂuorescein release
ratio equimolar to sphingomyelin, when indicated. To induce dye efﬂux, at time=0, 100 n
concentration), and the ﬂuorescence was monitored (25 °C). The data are expressed as perce
(mean±SEM from threemeasurements). (Right panel) Pelleted SM/DPPC/cholesterol liposo
monomer by immunoblotting using rabbit anti-GST and anti-rabbit IgG-peroxidase. Molecuconcentrations (0.2–2.0 nM) a pronounce lag phase in the surface
pressure changes was observed. The cooperative character of the
changes suggests that GST-lysenin WT undergoes self-aggregation in
solution. The lag phase became shorter with increasing protein
concentrations and was no longer detectable at 30 nM GST-lysenin
WT.
GST-lyseninW20A was also surface-active and induced changes of
the surface pressure in a dose-dependentmanner (Fig. 4B). Analysis of
the adsorption kinetics of GST-lyseninW20A showed that the rates offrom LUV composed of SM/DOPC, SM/DPPC (molar ratio 3:7) containing cholesterol in
M GST-lysenin WT or W20A was added to LUV suspension (1 mM total phospholipid
ntage of the total amount of carboxyﬂuorescein released from LUV by 0.1% Triton X-100
mes were subjected to SDS-PAGE and analyzed for the presence of lysenin oligomer and
lar weight standard positions (kDa) shown on the right.
Fig. 4. Adsorption of lysenin at the argon-water interface. (A, B) Kinetics of surface pressure changes caused by various concentrations of GST-lysenin WT (A) andW20A (B). Time of
protein injection to water sub-phase is marked with arrow. Plots shown are representative of three independent measurements. (C, D) Maximum increase (Δπ) in lateral pressure
caused by lysenin adsorption at the argon-water interface as a function of concentration of GST-lysenin WT (C) and GST-lysenin W20A (D) in the water sub-phase. The data are
mean±SEM from three experiments.
Fig. 5. Insertion of lyseninWT andW20A in lipid monolayers. Kinetics of surface pressure
increase caused by penetration of GST-lysenin WT (top panel) and GST-lysenin W20A
(lowerpanel) into theDOPC/cholesterolmonolayer spreadat theargon–water interface in
the absence or presence of sphingomyelin. Monolayers contained SM/DOPC/cholesterol
in 3:7:3 molar ratio or DOPC/cholesterol in 7:3 molar ratio. Time of protein injection
(30 nM) into water phase beneath the monomolecular layer at the surface pressure of
21 mN/m is marked with arrow. Plots shown represent one of three experiments.
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GST-lysenin WT but the saturation level of surface pressure was
substantially lower for the mutant lysenin. Additionally, the sigmoidal
shape of the surface pressure time dependences, observed for GST-
lyseninWT, did not obey in the case of GST-lyseninW20A, even at the
lowest protein concentration.
Fig. 4C and D summarizes the maximal change in surface pressure
(Δπ) as a function of lysenin concentration. For GST-lysenin WT, the
concentration dependence of Δπ displayed two saturation levels: at
about 12.5 mN/m and at about 20 mN/m. The data suggest that at the
protein concentrations above 15 nM the self-aggregation takes place;
the aggregated protein can affect Δπ more effectively than the non-
assembled protein. In contrast, for GST-lysenin W20A the maximum
change in surface pressure (Δπ) increased proportionally to the
concentration of the protein in the sub-phase and did not reach a
plateau in the investigated concentration range (Fig. 4D). Presumably,
the W20A mutation precludes the self-aggregation of lysenin. These
observations indicate also that the presence of the GST tag does not
determine abilities of GST-lysenin WT and W20A for oligomerization.
This notion is important in view of data that GST, naturally dimeric
[41], can evoked dimerization of fusion proteins containing this tag
[42,43], although other data are also available [44].
Fig. 5 shows changes in the surface pressure of mixed lipid
monomolecular layers spread at the argon-water interface, following
injection of 30 nMWT or W20A lysenin into the buffer sub-phase. The
binding of the proteins to the membranes was analyzed in terms of the
two-exponential dependency (Eq. (1)) reﬂecting the existence of two
phases of the process: the fast one characterized by the rate constant α,
and the slow one described by the rate constant β (Table 1). The rate
constants α and β of the binding ofWT lysenin to themixed SM/DOPC/
cholesterol monolayers (molar ratio 3:7:3) were found to be
Table 1
Kinetic analysis of lysenin insertion into lipid monolayers.
Lysenin form Lipid monolayer α (×103 s−1) α (%) β (×103 s−1) β (%) Q (×103 s−1) Δπ (mN/m)
WT SM/DOPC/CHOL 15.8±1.1 84 3.8±0.9 16 13.8±1.0 5.6±0.2
WT DOPC/CHOL 11.0±0.8 57 1.2±0.2 43 5.7±0.8 3.7±0.1
W20A SM/DOPC/CHOL 15.3±1.4 95 0.2±0.1 5 14.5±0.8 5.0±0.2
W20A DOPC/CHOL 12.0±1.2 94 0.01±0.008 6 11.3±0.5 3.9±0.1
The following lipid mixtures were used: SM/DOPC/cholesterol (molar ratio 3:7:3) or DOPC/cholesterol (molar ratio 7:3). Total phospholipid concentration was 1 mM. The kinetic
parameters were derived from experimental data on the change of surface pressure of monolayers as a function of time after injection of 30 nM GST-lysenin WT orW20A into water
sub-phase (see Fig. 5) and ﬁtted to a two-exponential equation (Eq. (2)). α and β—rate constants of the fast and slow phases of protein adsorption at the interface; percentage
contribution of the rates was calculated on the basis of the pre-exponential factors; Q—average rate constant; Δπ—total surface pressure change: difference between membrane
surface pressure at plateau and at the moment of injection of the protein into water sub-phase. Data shown mean±SEM from three experiments.
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maximum increase in the surface pressure of themonolayer,Δπ, was as
high as 5.6 mN/m. The insertion of GST-lysenin WT into the DOPC/
cholesterol (molar ratio 7:3) membrane devoid of sphingomyelin was
less effective and yielded a Δπ of 3.7 mN/m. The lack of sphingomyelin
in the system resulted in a pronounced decrease in both theα andβ rate
constants (Table 1). At these conditions the contribution of the slow β
component in the binding increased at the expense of the fast α
component and, therefore, the average rate representing the relative
binding efﬁciency Q (Eq. (2)) of GST-lysenin WT dropped from
13.8×10−3 s−1 in the case of sphingomyelin-containingmembranes
to 5.7×10−3 s−1 in the case of the sphingomyelin-lacking system
(Table 1). The presence of sphingomyelin inmonolayers also affected
the insertion of GST-lysenin W20A. The surface pressure changes (Δπ)
of the monolayer evoked by GST-lysenin W20A reached 5 mN/m with
sphingomyelin and 3.9 mN/m without sphingomyelin (Table 1). The
decreased range of the surface pressure changes was accompanied by
decreased rate constants α and β of the binding of GST-lysenin W20A to
DOPC/cholesterol monolayer. It should be noted that in the case of GST-
lysenin W20A the fast rate constant (α) of the protein adsorption to a
sphingomyelin-containing membrane contributed to the protein inser-
tion to a higher degree (95%) than it did for GST-lysenin WT (84%)
(Table 1). This difference can reﬂect adifferent organizationof theWTand
W20A lysenin molecules in the sphingomyelin-containing membranes.
3.5. Detergent-resistant membrane fragments are targets for
GST-lysenin WT
We examined whether the preferential interaction of GST-lysenin
WTwith sphingomyelin clusters would also be reﬂected in its binding
to various domains of the plasma membrane. To separate detergent-
resistant and detergent-soluble fractions of the plasma membrane,
0.2% Triton X-100 lysates of U937 monocytes were subjected toFig. 6. GST-lysenin WT but not GST-lysenin W20A is present in DRM fractions. U937 mono
lysed in 0.2% Triton X-100, fractionated over density gradients and analyzed for the distributi
and NTAL adaptor protein as two raft markers. In a series of experiments living cells were tre
with the anti-FcγRIIA IgG-biotin and goat anti-mouse IgG (receptor activated). Distribution
standard positions are shown between gels in kDa.density gradient ultracentrifugation. A line of previous data indicated
that the detergent-resistant membranes isolated at these conditions
in buoyant fractions 1–2 of the gradient are derived from rafts which
serve as sites of accumulation of activated immunoreceptor FcγIIA
and signal generation [10,16,18]. We found that GST-lysenin WT
incubated with cells prior to lysis was recovered mainly in the low
density fractions 1–2 of the gradient (Fig. 6). Only oligomers over
350 kDa, probably corresponding to lysenin hexamers, were detected.
Fractions 1–2 of the gradient also contained a distinct pool of Lyn
kinase and NTAL adaptor protein, two markers of rafts. On the other
hand, fractionation of lysates of cells preincubated with GST-lysenin
W20A revealed that the mutant lysenin was found only as monomers
of about 63 kDa in fractions 6–7 of high density where Triton X-100-
soluble proteins were located (Fig. 6). Activation of FcγRIIA led to a
shift of the receptor from the high-density fractions 5–7 towards
fractions 1–2 of density gradients (Fig. 6).
To follow the dynamics of sphingomyelin in the plasmamembrane
we labeled with lysenin the surface of resting cells and cells after
FcγRIIA activation (Fig. 7). In resting cells FcγRIIA was uniformly
distributed over the cell surface while GST-lysenin WT formed
numerous tiny clusters as revealed by three-dimensional analysis of
the distribution of intensity of ﬂuorescence attributed to the receptor
and to lysenin (Fig. 7A and A'). The GST-lysenin WT ﬂuorescence dots
were dispersed across the membrane with distinct labeling of cell
edges (Fig. 7A'). Activation of FcγRIIA led to a prominent receptor
clustering in the plane of the plasma membrane (Fig. 7C), conﬁrming
earlier reports [10,45]. Surprisingly, at those conditions we detected
simultaneous clustering of the sphingomyelin label (Fig. 7C').
However, in contrast to the distinct spikes of ﬂuorescence attributed
to the receptor, sphingomyelin decoration by GST-lysenin WT was
often observed as dense assemblies of 3–5 adjacent ﬂuorescence
peaks (Fig. 7C and C', lower panel). GST-lyseninW20A stained the cell
surface diffusively and formed crude intense dots concentrated overcytes were incubated with 20 nM GST-lysenin WT or with 200 nM GST-lysenin W20A,
on of GST-lyseninWT and GST-lyseninW20A revealed by the GST tag, and for Lyn kinase
ated either with mouse IgG anti-FcγRIIA labeled with biotin (receptor non-activated) or
of FcγRIIA in gradient fractions was revealed with anti-biotin IgG. Molecular weight
Fig. 7. Activation of FcγRIIA induces redistribution of plasmamembrane sphingomyelin decoratedwith GST-lyseninWT but not with GST-lyseninW20A. Cells were either exposed to
IV.3 anti-FcγRIIA mouse IgG and ﬁxed (non-activated FcγRIIA, upper panel) or incubated with the IV.3 anti-FcγRIIA mouse IgG followed by goat anti-mouse IgG-Texas Red prior to
ﬁxation (activated FcγRIIA, lower panel). The ﬁxed cells were subsequently incubated either with 20 nM GST-lysenin WT (A, A' and C, C') or 200 nM GST-lysenin W20A (B, D)
followed by rabbit anti-lysenin IgG and goat anti-rabbit IgG-FITC. After examination under a ﬂuorescent microscope, distribution and intensity of ﬂuorescence signals attributed to
FcγRIIA (A, C), GST-lysenin WT (A', C') and GST-lysenin W20A (B, D) were analyzed in marked areas of the plasma membrane (8×8 μm) and displayed as three-dimensional maps
shown at the bottom of corresponding cell images. Data representative for two experiments are shown.
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affected by activation of FcγRIIA (Fig. 7B and D).
To estimate possible colocalization of lysenin with activated
FcγRIIA a quantitative analysis was performed of dual-color confocal
images of either GST-lyseninWT or GST-lyseninW20 and the receptor
(Supplementary Fig. 1 online). For that, three different quantities
were calculated (Table 2), starting with the Pearson's correlation
coefﬁcient which provides information about the similarity of shape
between two images without regard to the average intensity of the
signals [34]. The value for co-immunostaining of GST-lysenin W20A
and activated FcγRIIA was very low (about 0.22 in relation to 1 as the
maximal value), while for GST-lyseninWT and the receptor it reached0.32 (Table 2). The overlap coefﬁcient had higher values than those of
the Pearson's correlation (Table 2). However, this parameter is
strongly affected by differences in the ﬂuorescence patterns between
the compared images [34]. Finally, a lack of co-localization of GST-
lysenin W20A and FcγRIIA and moderate co-localization of WT
lysenin and the receptor was indicated by the colocalization rate
calculated as the percentage of area where the two ﬂuorescences
coincided. For comparison, the Pearson's correlation coefﬁcient and
the overlap coefﬁcient calculated for tyrosine-phosphorylated pro-
teins and activated FcγRIIA were as high as 0.67–0.81 and the
colocalization rate of the two signals reached 76% (Table 2), which is
in agreement with previous observations [10]. As labeling of tyrosine-
Table 2
Quantiﬁcation of colocalization of GST-lysenin WT and GST-lysenin W20A with activated FcγRIIA.
Co-immunostaining Pearson's correlation Overlap coefﬁcient Colocalization rate
GST-lysenin WT/activated FcγRIIA (no detergent) 0.32±0.01 0.59±0.03 43.44%±1.60%
GST-lysenin WT/activated FcγRIIA (digitonin-treated) 0.45±0.01 0.60±0.01 49.66%±1.28%
GST-lysenin WT/activated FcγRIIA (TX-treated) 0.44±0.02 0.56±0.02 45.31%±0.81%
GST-lysenin W20/activated FcγRIIA (no detergent) 0.22±0.01 0.49±0.01 25.21%±1.88%
PY-proteins/activated FcγRIIA (digitonin-treated) 0.78±0.01 0.81±0.05 76.56%±1.76%
PY-proteins/activated FcγRIIA (TX-treated) 0.67±0.03 0.75±0.02 69.35%±2.06%
For comparison, colocalization of tyrosine-phosphorylated proteins (PY-proteins) with the receptor was estimated. To activate FcγRIIA, cell were exposed to IV.3 anti-FcγRIIAmouse
IgG and goat anti-mouse IgG-Texas Red. After ﬁxation, the cells were incubated with GST-lysenin WT or W20A followed by rabbit anti-lysenin IgG and goat anti-rabbit IgG-FITC (no
detergent treatment). In a series of experiments, cells after ﬁxation but prior to lysenin binding were treated either with 0.05% Triton X-100 or 0.005% digitonin. When tyrosine-
phosphorylated proteins were analyzed, cell after activation of FcγRIIA were ﬁxed, treated either with 0.05% Triton X-100 or 0.005% digitonin and labeled with rabbit anti-
phosphotyrosine followed by goat anti-rabbit IgG conjugated with FITC. Colocalization of proteins was analyzed in images of 40 cells from three independent experiments for each
variant. Data shown are mean±SEM.
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0.005% digitonin or 0.05% Triton X-100, colocalization of GST-lysenin
WT and activated FcγRIIA was also estimated at these conditions
(Table 2). It was found that both detergents promote colocalization of
lysenin WT and activated receptor, as reﬂected by an increase in the
Pearson's correlation values for the two proteins in permeabilized
cells (Table 2).
4. Discussion
The interest in distribution of sphingolipids in membranes has
been increasing with the discovery of sphingolipid/cholesterol
microdomains in the plasma membrane and their postulated
involvement in various cellular functions, including signal transduc-
tion. Studies on raft structure and function have drawn attention to
protein probes of cholesterol and sphingomyelin, with lysenin as an
example of the latter [30].
In this report we demonstrated that lysenin WT recognized
sphingomyelin present in a detergent-resistant fraction of the plasma
membrane that was attributed to rafts. In contrast, the W20A mutant
lysenin was absent from this fraction and occupied fractions of high
density in which detergent-soluble components of the plasma
membrane were recovered. The data are in line with the results of
SPR studies performed on model membranes showing that high
amounts of lysenin WT bound to SM/DOPC, SM/DOPC/cholesterol
and SM/DPPC/cholesterol but not SM/DPPC liposomes, thus pointing
to the importance of phase separation of sphingomyelin in the plane of
the membrane for the protein binding. Lysenin W20A has apparently
lost the ability of preferential interaction with sphingomyelin-rich
clusters, as it bound in similar amounts to liposomes containing
sphingomyelin mixed with DOPC and DPPC. Mixtures of sphingo-
myelin with DOPC or DPPC have been used previously to force homo-
or heterogeneous distribution of sphingomyelin in membranes. It
was shown by differential scanning calorimetry that semi-synthetic
brain C16:0 sphingomyelin was fully miscible with DPPC at all the
ratios studied [36]. Accordingly, we used a mixture of the semi-
synthetic brain C16:0 sphingomyelin with DPPC (molar ratios 1:1
and 3:7) to prepare membranes with homogenous sphingomyelin
distribution. AFM studies conﬁrmed uniform lipid distribution in the
obtained SM/DPPC (molar ratio 3:7)membrane (Fig. 2C). In contrast,
in the mixture with DOPC, C16:0 sphingomyelin separated in the
plane of the plasma membrane forming a heterogeneous population
of small and large domains (Fig. 2A, SM/DOPC at molar ratio 3:7).
Although not exactlymatching, this lipidmixture can correspond to a
mixture of egg PC (PC containing saturated and unsaturated fatty acyl
chains, according to Avanti data) with brain sphingomyelin at above
33 mol%. Separation of gel phase sphingomyelin from the PC-rich
liquid crystalline phase was detected in membranes of such lipid
composition at 20 °C [46]. Furthermore, separation of sphingomye-
lin-rich and DOPC-rich phaseswaswell documented by AFM analysis
of membranes with a higher content of brain or C16:0 sphingomyelin(SM/DOPC at molar ratio 1:1) [37–39]. Those conditions correspond
to these of our SPR studies.
After supplementation of an SM/DOPC mixture with cholesterol,
sphingomyelin formed a liquid-ordered phase that still co-existed
with the liquid-disordered phase in the membrane, as shown by
spectroscopic studies [47]. Addition of cholesterol to C16:0 SM/DOPC
in the range of 10–50 mol% has been reported to induce a progressive
increase of the size of the sphingomyelin-rich domains visualized by
AFM [37,38]. In our hands, enrichment of SM/DOPC liposomes with
cholesterol (molar ratio 1:1:1) only moderately increased the
amounts of lysenin WT bound to liposomes (Fig. 1A) and did not
change substantially the appearance of SM/DOPC membrane in AFM
(SM/DOPC/cholesterol at molar ratio 3:7:3; Fig. 2A and B). In
contrast, cholesterol added to a mixture of SM and DPPC markedly
facilitated the binding of lysenin WT to liposomes (Fig. 1A). Of note,
cholesterol concomitantly induced a shift from a homo- to a
heterogenous distribution of sphingomyelin in SM/DPPC membranes
[Fig. 2C and D, and 25,40]. The data showing facilitated binding of
lysenin WT to SM/DPPC/cholesterol membranes are in agreement
with other reports showing that lysenin WT is prone to binding
sphingomyelin separated from PC into domains in membranes [25]. It
is of note that cholesterol has also been shown to facilitate lyseninWT
oligomerization by increasing ﬂuidity of sphingomyelin-containing
membranes [27]. This effect, in addition to phase separation, can
contribute to the increase of the amount of lysenin WT bound to
cholesterol-containing liposomes on the BIAcore sensor and the
signiﬁcant release of carboxyﬂuorescein from liposomes (Fig. 1A,
Fig. 3). The mutant GST-lysenin W20A did not discriminate in its
binding between sphingomyelin mixed with DOPC or DPPC, regardless
of cholesterol presence (Fig. 1B).
The loss of the preference of GST-lysenin W20A to bind
sphingomyelin microdomains correlated with an inability of the
mutant protein to oligomerize and the parallel loss of the lytic activity.
SPR analysis indicated that less GST-lyseninW20A remained bound to
sphingomyelin-containing liposomes in comparisonwith GST-lysenin
WT. Theweaker interaction of GST-lyseninW20Awith sphingomyelin
was conﬁrmed by the protein/lipid overlay and liposome binding
assays (not shown). Furthermore, the surface pressure changes
induced by lysenin W20A both at the argon–water interface and in
sphingomyelin-containing monolayers were lower than those in-
duced by the same concentrations of lysenin WT. The data indicate
that the mutant lysenin is more hydrophilic, with a limited ability to
penetrate the hydrophobic region of membranes. Measurements of
the surface pressure changes of a monomolecular layer showed that
upon binding to sphingomyelin-containing membrane, GST-lysenin
WT andW20A share a common fast phase of the process described by
the rate constant α (Table 1). The lack of the slow phase β in the
binding of GST-lysenin W20A probably reﬂects the inability of the
protein to insert and form stable hexamers in the membrane. All the
data suggest that formation of stable oligomers by lysenin WT
enhances its binding to sphingomyelin clusters in a positive feedback
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interaction of GST-lysenin W20A with sphingomyelin clusters.
Formation of stably oligomers in sphingomyelin-containing mem-
branes by lyseninWT correlates with self-assembly of the protein into
trimers even in the absence of the lipid [31]. Accordingly, self-
association of GST-lysenin WT, but not lysenin GST-lysenin W20A, is
suggested by the sigmoidal shape of the plots of surface pressure
versus time recorded for lysenin WT only.
Studies of lysenin W20A provide new information on the
organization of lysenin WT oligomers in membranes. A prediction of
the secondary structure of lysenin suggested the existence of an α-
helix encompassing residues G256-T267 and two possible α-helices
located in the middle and at the N-terminus of the protein [24]. Linear
dichroism measurements showed that the C-terminal α-helix can
penetrate lipid bilayers [31]. Deletion of the C-terminal fragment
starting from amino acid 247 abolished the binding of lysenin to
sphingomyelin [30]. A similar effect was exerted bymutation of any of
the W116, W187, W245 or W291 residues [23]. Based on these data
we suggest that the C-terminal α-helix, in cooperation with the
indicated tryptophan residues, becomes embedded in the membrane.
However, these interactions are not sufﬁcient to stably anchor the
protein in the membrane judging from the weak binding of GST-
lysenin W20A. The irreversible binding of lysenin requires an
involvement of the N-terminus which governs the protein oligomer-
ization and concomitant formation of a membrane pore. Presumably
also the N-terminus becomes inserted into the membrane. The W20A
mutation as well as truncation of the N-terminal 60 amino acid
residues disable the second stage of the lysenin–sphingomyelin
interaction and suppress the lytic activity of lysenin [28,30].
Antibodies directed against distinct C- or N-terminal regions of
lysenin did not recognize oligomers of lysenin WT, supporting the
suggestion that those protein fragments are buried in the membrane
[22]. Large, SDS-sensitive conglomerates of lyseninW20A revealed by
native electrophoresis in sphingomyelin-containing membranes [28]
indicate that the mutant forms aggregates different from the small,
regular assemblies composed of six monomers of lysenin WT. The
conglomerates of mutant lysenin probably do not penetrate the
membrane, as indicated by the lack of the channel and lytic activities
of the protein [28 and this report].
When applied to detect sphingomyelin on the cell surface, GST
lysenin WT and W20A displayed different patterns of staining, with
large aggregates observed for themutant lysenin only. Concomitantly,
lysenin WT and W20A were recovered in detergent-resistant and
detergent-soluble fractions of the plasma membrane, respectively.
The exclusive partitioning of GST-lysenin WT to the membrane
fractions believed to originate from rafts is in line with the results of
studies on the interaction of GST-lysenin WT with sphingomyelin
clusters inmodelmembranes discussed above. Rafts serve as signaling
platforms for the immunoreceptor FcγRIIA [10,16]. The receptor
associates with the rafts upon activation, which is reﬂected by its shift
from high to low density fractions where it co-exists with signaling
proteins like Lyn kinase and NTAL as well as with oligomers of GST-
lysenin WT. However, when visualized in intact cells, activated
FcγRIIA colocalized moderately with lysenin WT oligomers (Supple-
mentary Fig. 1 online and Table 2). Such separation can ensue from
steric hindrance imposed on the lysenin-sphingomyelin interaction
by gangliosides occupying the rafts [30]. On the other hand, lysenin
can selectively bind to sphingomyelin located at the edges of rafts,
where defects in lipid packing favor protein–lipid interactions. It has
been suggested that such defects in lipid packing increase the
accessibility of sphingomyelin to equinatoxin II, another sphingo-
myelin-speciﬁc pore-forming protein toxin originating from Actinia
equina [21,48,49]. A similar mechanism was proposed to govern the
interaction of PLA2 and glicerophospholipids in the course of the
action of the enzyme [50], pointing to the lipid-phase boundaries as
sites of binding of water-soluble proteins with their lipid targets [51].Despite the separated decorations of FcγRIIA and sphingomyelin, the
receptor- and sphingomyelin-rich domains seem to be functionally
related since receptor activation affected sphingomyelin distribution
as revealed by GST-lysenin WT (Fig. 7). We assume that the inability
of GST-lysenin W20A to oligomerize affects its interaction with
sphingomyelin in the plasma membrane. The weak binding of the
mutant lysenin to sphingomyelin can prevent it stably docking in rafts
(at their edges); as a result, large “invalid oligomers” of GST-lysenin
W20A are formed outside rafts and are recovered in detergent-soluble
membrane fractions (Fig. 6). Accordingly, activation of FcγRIIA did not
change the pattern of plasma membrane decoration by the W20A
mutant lysenin.
Taken together, the presented data suggest that only lysenin WT
recognizes raft sphingomyelin where it forms stable oligomers. The
mutant lysenin W20A, which does not oligomerize, interacts with
another pool of the lipid, the existence of which has been suggested
earlier [17,18]. The results shed new light on the data on sphingo-
myelin distribution in the plasma membrane revealed by monomeric
non-toxic lysenin [30].
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